RDY

· Pharmaceuticals

Dr. Reddy's Laboratories

Q: How much does RDY stock cost right now?

RDY last closed at $13.28, down 1.41% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $1,020.00 and a high of $1,379.70. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Q: What is the analyst consensus for RDY?

Among 44 analysts covering RDY, the consensus rating is Sell — 22 rate it a buy, 11 hold, and 11 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Q: Does Dr. Reddy's Laboratories make money?

Dr. Reddy's Laboratories generated $31.32T in revenue during fiscal year 2026, with $5.43T reaching the bottom line as net income. The net profit margin of 17.3% is solid for its sector.

Q: Is RDY stock expensive based on earnings?

RDY trades at a P/E ratio of 19.50 on trailing earnings of $66.81 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Pharmaceuticals sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$13.28

-0.19 (-1.41%)

As of Apr 2, 4:56 PM ET ·

Day Range $13.03 — $13.33

52W Range $1,020.00 — $1,379.70

Open$13.16

Previous Close$13.47

Day High$13.33

Day Low$13.03

52W High$1,379.70

52W Low$1,020.00

Volume—

Avg Volume1.81M

Market Cap1.09T

P/E Ratio19.50

EPS$66.81

SectorPharmaceuticals

Analyst Ratings

Sell

44 analysts

22 Buy 11 Hold 11 Sell

Key Financials

	FY 2026	FY 2025
Revenue	31.32T	27.27T
Net Income	5.43T	4.25T
Profit Margin	17.3%	16.5%
EBITDA	8.53T	7.05T
Free Cash Flow	—	—
Rev Growth	+14.9%	+14.9%
Debt/Equity	0.14	0.14

Dividend

Dividend Yield0.61%

Annual Dividend$8.00

Payout Ratio11.8%

Frequencyquarterly

Ex-Dividend—

Pay Date—

Pharmaceuticals Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
LLY	Eli Lilly and Co.	$935.58	-1.98%	46.4	957.52B
JNJ	Johnson & Johnson	$243.04	-0.44%	22.2	594.00B
MRK	Merck & Co. Inc.	$120.87	+0.02%	16.5	301.17B
PFE	Pfizer Inc.	$28.32	-0.81%	19.8	153.76B
BMY	Bristol-Myers Squibb Co	$59.60	-3.45%	16.9	119.16B
ZTS	Zoetis Inc	$117.94	+0.55%	21.5	57.37B

RDY News

No news for RDY yet

Quick Stats

Market Cap1.09T

P/E Ratio19.50

EPS$66.81

Div Yield0.61%

Volume—

SectorPharmaceuticals

RDY Frequently Asked Questions

How much does RDY stock cost right now?

RDY last closed at $13.28, down 1.41% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $1,020.00 and a high of $1,379.70. The current price represents 0% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

What is the analyst consensus for RDY?

Among 44 analysts covering RDY, the consensus rating is Sell — 22 rate it a buy, 11 hold, and 11 sell. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

Does Dr. Reddy's Laboratories make money?

Dr. Reddy's Laboratories generated $31.32T in revenue during fiscal year 2026, with $5.43T reaching the bottom line as net income. The net profit margin of 17.3% is solid for its sector.

Is RDY stock expensive based on earnings?

RDY trades at a P/E ratio of 19.50 on trailing earnings of $66.81 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Pharmaceuticals sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.